売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2017/4 |
17,402 |
- |
| 2016/4 |
25,182 |
- |
| 2014/4 |
30,399 |
- |
| 2013/4 |
27,616 |
- |
| 2012/4 |
36,079 |
- |
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2025/4 |
-13,006 |
- |
| 2024/4 |
-7,257 |
- |
| 2023/4 |
-9,401 |
- |
| 2022/4 |
-14,952 |
- |
| 2021/4 |
-12,387 |
- |
| 2019/4 |
-7,611 |
|
| 2018/4 |
-8,263 |
|
| 2017/4 |
-1,767 |
|
| 2016/4 |
-1,240 |
|
| 2014/4 |
-2,321 |
|
| 2013/4 |
-4,279 |
|
| 2012/4 |
-6,881 |
|
|
(単位:%)
|
2012/4
|
2013/4
|
2014/4
|
2016/4
|
2017/4
|
2018/4
|
2019/4
|
2020/4
|
2021/4
|
2022/4
|
2023/4
|
2024/4
|
2025/4
|
|
売上高
|
36,079
|
27,616
|
30,399
|
25,182
|
17,402
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
売上成長率(%)
|
-
|
|
|
-
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
売上原価
|
42,960
|
31,895
|
32,720
|
26,422
|
19,169
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
研究開発費
|
0
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
販売管理費
|
12,324
|
8,700
|
7,181
|
5,767
|
4,516
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
営業費用
|
-
|
-
|
-
|
-
|
-
|
8,262
|
7,611
|
5,687
|
12,387
|
14,952
|
9,400
|
7,257
|
13,005
|
|
営業利益
|
-6,881
|
-4,279
|
-2,321
|
-1,240
|
-1,767
|
-8,263
|
-7,612
|
-
|
-12,388
|
-14,953
|
-9,401
|
-7,258
|
-13,006
|
|
営業利益率 (%)
|
|
|
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
経常(税引前)利益
|
-3,254
|
-4,620
|
-2,609
|
-1,408
|
-1,915
|
-8,263
|
-7,612
|
-5,688
|
-12,388
|
-13,931
|
-7,615
|
-6,898
|
-20,560
|
|
経常(税引前)利益率(%)
|
-9.0
|
-16.7
|
-8.6
|
-5.6
|
-11.0
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
法人税等合計
|
5
|
5
|
-
|
-3
|
-
|
-436
|
435
|
-439
|
-
|
-
|
-
|
-
|
-
|
|
実効税率(%)
|
|
|
-
|
|
-
|
|
|
|
-
|
-
|
-
|
-
|
-
|
|
純利益
|
-3,259
|
-4,625
|
-2,609
|
-1,221
|
-1,915
|
-13,659
|
-8,047
|
-5,250
|
-12,388
|
-13,900
|
-7,600
|
-6,900
|
-20,600
|
|
純利益率(%)
|
|
|
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
一株あたり利益
|
-0.31
|
-2.6
|
-1.3
|
-
|
-
|
-
|
-
|
-
|
-
|
-1.92
|
-0.9
|
-0.74
|
-1.8
|
|
希薄化後一株あたり利益
|
-0.31
|
-2.6
|
-1.3
|
-
|
-
|
-
|
-
|
-
|
-
|
-1.92
|
-0.9
|
-0.74
|
-1.8
|
|
EBITDA
|
|
|
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
EBITDAマージン(%)
|
|
|
|
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|